- Male circumcision (MC) reduces women's risk for oncogenic HPV genotypes, cervical cancer, Trichomonas vaginalis, bacterial vaginosis, and possibly genital ulcer disease.
Why this matters
- The reduction in risk for these sexually transmitted decisions (STIs) and cervical cancer affirms global efforts to deploy MC as a health-promoting and life-saving public health measure.
- Researchers reviewed published reports of 82 observational studies and randomized controlled trials (RCTs) related to MC and female STIs.
- Funding: None disclosed.
- MC was associated with a reduced risk for female infection by oncogenic human papillomavirus (HPV) genotypes and risk of contracting cervical cancer.
- RCT data confirmed that partner MC reduces women's risk for oncogenic HPV as well as for T vaginalis, bacterial vaginosis, and possibly genital ulcer disease.
- Evidence is mixed concerning the associations between MC and herpes simplex virus type 2, Chlamydia trachomatis, Treponema pallidum, HIV, and candidiasis.
- MC did not reduce women’s risk for gonorrhea, Mycoplasma genitalium, dysuria, or vaginal discharge.
- Researchers found no RCT data related to MC's associations with women’s risk for HSV-2, C trachomatis, Neisseria gonorrhoea, T pallidum, M genitalium, candida, and dysuria.